A multicenter, randomized, controlled trial for integrated Chinese and western medicine in the treatment of ordinary novel coronavirus pneumonia (COVID-19) based on the ' Internal and External Relieving -Truncated Torsion' strategy

Phase 4

• Conditions: ovel Coronavirus Pneumonia (COVID-19)

• Registration Number: ITMCTR2000003019
• Lead Sponsor: Huangshi Hospital of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. patients with novel coronavirus pneumonia confirmed by pathogenic detection;
2. Fever, respiratory tract and other symptoms, the change of pneumonia can be seen in imaging;
3. Aged 18 to 80 years;
4. Signed informed consent.

Exclusion Criteria

1. Pregancy or lactating women;
2. People with allergies or allergies to traditional Chinese medicine
3. Severe Primary disease such as uncontrolled and metastasis malignancy, hematopathy, HIV;
4. Obstructive pneumonia caused by lung tumors, severe pulmonary interstitial fibrosis, alveolar proteinosis, allergic reaction alveolitis;
5. Previous immunodepressant within 6 months before study entry or Receipt of a solid-organ or bone marrow transplant;
6. Severe mental illness or inability to cooperate with investigators.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
lung CT;14 day outcome of the subjects, including: recovery, improvement, turning critical, death.;

Secondary Outcome Measures

Name	Time	Method
inflammatory biomarkers;Routine Blood;Pneumonia symptoms;Coagulation index;oxygenation index;major organ function;